Press Release

Invoke Capital's Darktrace and SOPHiA GENETICS amongst Fast Company's 'Most Innovative Companies' 2018

  • Darktrace ranked 3rd in the 'Artificial Intelligence' category
  • SOPHiA GENETICS ranked 5th in the 'Biotech' category

  • 27th Feb 2018

    Invoke Capital, the technology investment fund dedicated to unlocking the potential of European technology, today announces that two of its portfolio companies have been selected as 2018's 'Most Innovative Companies' by Fast Company, the media brand.

    World leading AI company for cyber defense, Darktrace, joins the list alongside Apple, Amazon and Netflix, and is the only cyber security company to feature in the edition. Darktrace uses machine learning and AI algorithms to detect and respond to cyber-threats across diverse digital environments in real time. Simultaneously, global leader in data-driven medicine, SOPHiA GENETICS, was ranked 5th in the 'Top 10 Most Innovative Companies in Biotech' for its use of AI to solve the complexity of genomic data analysis.

    The 2018 edition of Fast Company's 'World's Most Innovative Companies' spans over 350 enterprises across 36 categories, celebrating inspirational companies. More than three dozen editors, reporters and contributors surveyed thousands of companies to identify the most notable innovations of the year and trace their impact on businesses, industries, and culture.

    "Darktrace's Enterprise Immune System slows attacks on computing systems by emulating the way humans fend off viruses," commented Fast Company. "The AI-enabled platform embeds in a network, learns what behaviours are normal, and flags anomalies. It became more formidable last April with the launch of Antigena, which automatically stops or slows compromised networks and devices."

    Founded in 2012 by some of Europe's most successful technology entrepreneurs, Invoke Capital invests in, and supports, world-leading fundamental technology businesses emerging across Europe. The firm launched Darktrace in 2013, which is now valued at $875million and invested in genomics specialist SOPHiA GENETICS in 2014, which has helped diagnose more than 177,000 patients to date.

    Invoke Capital's portfolio also includes Luminance, an artificial intelligence platform for lawyers which uses machine learning to read and analyse contracts. Launched in September 2016, Luminance is already in use on five continents by the world's leading law firms.